XPH holdings: all 62 positions
XPH held 62 positions as of Oct 13, 2026. Xeris Biopharma Holdings Inc is the largest at 2.75%; the top 10 are 23.2% of the fund.
Every position
| # | Holding | Ticker | Weight ↓ |
|---|---|---|---|
| 1 | Xeris Biopharma Holdings Inc | XERS | 2.75% |
| 2 | Pacira BioSciences Inc | PCRX | 2.64% |
| 3 | VeraDermics Inc | MANE | 2.43% |
| 4 | Amneal Pharmaceuticals Inc | AMRX | 2.36% |
| 5 | Perrigo Co PLC | PRGO | 2.23% |
| 6 | Ligand Pharmaceuticals Inc | LGND | 2.19% |
| 7 | Viatris Inc | VTRS | 2.18% |
| 8 | Eli Lilly & Co | LLY | 2.16% |
| 9 | Pfizer Inc | PFE | 2.13% |
| 10 | Indivior Pharmaceuticals Inc | INDV | 2.12% |
| 11 | Corcept Therapeutics Inc | CORT | 2.12% |
| 12 | Zoetis Inc | ZTS | 2.11% |
| 13 | Organon & Co | OGN | 2.10% |
| 14 | ANI Pharmaceuticals Inc | ANIP | 2.09% |
| 15 | Supernus Pharmaceuticals Inc | SUPN | 2.08% |
| 16 | Prestige Consumer Healthcare Inc | PBH | 2.07% |
| 17 | Innoviva Inc | INVA | 2.04% |
| 18 | Omeros Corp | OMER | 2.03% |
| 19 | Maze Therapeutics Inc | MAZE | 2.01% |
| 20 | Merck & Co Inc | MRK | 2.00% |
| 21 | Elanco Animal Health Inc | ELAN | 1.98% |
| 22 | Royalty Pharma PLC | RPRX | 1.94% |
| 23 | Johnson & Johnson | JNJ | 1.94% |
| 24 | Eton Pharmaceuticals Inc | ETON | 1.89% |
| 25 | Definium Therapeutics Inc | DFTX | 1.89% |
| 26 | Collegium Pharmaceutical Inc | COLL | 1.88% |
| 27 | Septerna Inc | SEPN | 1.87% |
| 28 | Harmony Biosciences Holdings Inc | HRMY | 1.85% |
| 29 | Bristol-Myers Squibb Co | BMY | 1.83% |
| 30 | Jazz Pharmaceuticals PLC | JAZZ | 1.82% |
| 31 | Tarsus Pharmaceuticals Inc | TARS | 1.78% |
| 32 | Edgewise Therapeutics Inc | EWTX | 1.74% |
| 33 | Amylyx Pharmaceuticals Inc | AMLX | 1.73% |
| 34 | Amphastar Pharmaceuticals Inc | AMPH | 1.63% |
| 35 | MBX Biosciences Inc | MBX | 1.62% |
| 36 | Harrow Inc | HROW | 1.57% |
| 37 | Axsome Therapeutics Inc | AXSM | 1.55% |
| 38 | Trevi Therapeutics Inc | TRVI | 1.54% |
| 39 | Zevra Therapeutics Inc | ZVRA | 1.53% |
| 40 | Nuvation Bio Inc | NUVB | 1.51% |
| 41 | Enliven Therapeutics Inc | ELVN | 1.43% |
| 42 | Alumis Inc | ALMS | 1.39% |
| 43 | Ocular Therapeutix Inc | OCUL | 1.31% |
| 44 | LB Pharmaceuticals Inc | LBRX | 1.31% |
| 45 | Rapport Therapeutics Inc | RAPP | 1.28% |
| 46 | CorMedix Inc | CRMD | 1.26% |
| 47 | Phibro Animal Health Corp | PAHC | 1.26% |
| 48 | Aquestive Therapeutics Inc | AQST | 1.23% |
| 49 | Wave Life Sciences Inc | WVE | 1.22% |
| 50 | Phathom Pharmaceuticals Inc | PHAT | 1.14% |
| 51 | Alto Neuroscience Inc | ANRO | 1.12% |
| 52 | Relmada Therapeutics Inc | RLMD | 0.88% |
| 53 | Liquidia Corp | LQDA | 0.81% |
| 54 | Aclaris Therapeutics Inc | ACRS | 0.80% |
| 55 | Avalyn Pharma Inc | AVLN | 0.74% |
| 56 | Lexicon Pharmaceuticals Inc | LXRX | 0.73% |
| 57 | Evolus Inc | EOLS | 0.71% |
| 58 | EyePoint Inc | EYPT | 0.70% |
| 59 | Arvinas Inc | ARVN | 0.69% |
| 60 | BioAge Labs Inc | BIOA | 0.57% |
| 61 | Contineum Therapeutics Inc | CTNM | 0.43% |
| 62 | Esperion Therapeutics Inc | 0.01% | |
| SSI US Gov Money Market Class | 0.08% | ||
| US Dollar | 0.00% | ||
| Cash and other net assets | −0.03% |
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of XPH, data as of Oct 13, 2026. https://etfiq.com/funds/xph/holdings/
ETFIQ. (Oct 13, 2026). Holdings of XPH. Retrieved from https://etfiq.com/funds/xph/holdings/
[Holdings of XPH (ETFIQ, Oct 13, 2026)](https://etfiq.com/funds/xph/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.